INSULIN DEGLUDEC FOR IMPROVEMENT OF GLYCAEMIC CONTROL AND REDUCTION OF ACUTE AND LONG-TERM DIABETES COMPLICATIONS
- 专利权人:
- Novo Nordisk A/S
- 发明人:
- Per Knud Christensen,Thue Johansen,Simon Skibsted,Kajsa Kvist
- 申请号：
- US16463594
- 公开号：
- US20200181222A1
- 申请日:
- 2017.11.28
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention relates to insulin degludec for use in medicine.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Insulin degludec for improved glycemic control and reduction of acute and long-term diabetic complications
- Medical composition to be used for improvement of diabetes and its complications
- Type II diabetes mellitus and diabetes mellitus defatted combined therapy
- 糖尿病治療剤
- SULPHONAMIDES FOR PREVENTION OF DIABETES
